FY 2008 Appropriations for R&D and Public Health Programs (in millions)

Similar documents
President's FY 2009 Budget Request for R&D and Public Health Programs

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Planning, Priority Setting, and Budget Development for NIH AIDS Research

The NIH SBIR/STTR Program & Universities

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

FY2019 Labor, Health and Human Services, Education Appropriations Summary

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

BD-STEP: Tackling Key Issues Across Cancer Research and Care

FY2019 Labor, Health and Human Services, Education Appropriations Summary

FY2018 Labor, Health and Human Services, Education Appropriations Summary

The NIH STTR Program

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000

Fogarty Initiatives for Building Capacity in HIV/AIDS

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

FY 2015 OMNIBUS SPENDING BILL

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)

FY19 Labor, Health and Human Services, and Education Appropriations Bill

Public Health Emergencies: Mass Dispensing in the Community

Research Training Opportunities at the National Institute on Aging

Thank You. Presented By. Title Sponsor. Venue Host

OBTAINING A MENTORED CAREER DEVELOPMENT AWARD: PERSPECTIVES OF A MENTOR, APPLICANT AND REVIEWER

Dietary Supplement Research Portfolio at the NIH, ,2

Overview of the NIH. National Institutes of Health (NIH)

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

Composed of 27 Institutes and Centers.

MARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES

Pandemic Influenza Preparedness and Response

Re: Trust for America s Health Comments on Biennial Implementation Plan for the National Health Security Strategy

NIAID Biodefense Research Agenda

Financing Influenza Vaccine R&D

ANALYSIS OF THE ADMINISTRATION S FISCAL YEAR 2004 BUDGET FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION

CRS Report for Congress

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Bioterrorism: Assessing the Threat

Emergency Use Authorizations

CRS Report for Congress

CDC Prepares Special Issue August 2006

Emerging Infectious Disease Threats. Margaret A. Hamburg M.D. Foreign Secretary, U.S. National Academy of Medicine

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning

Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06)

September 7, Dear Director Mulvaney:

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals

Prepared for Members and Committees of Congress

Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES

Infectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho. Assignment Description

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

Conversation with Tom Inglesby on October 2, 2013

Labor, Health and Human Services & Education Labor, Health and Human Services & Education

Public Safety and Health Cooperation from the Canadian Perspective

U.S. Readiness for Pandemics

National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson

Product Development for Public Health & Emerging Infections

State Of Tuberculosis Elimination in the United States, 2017

Lita M. Proctor, Ph.D. NHGRI/NIH. for NIH Human Microbiome Project. April 11, 2011 Health Disparities Summit

Pandemic Influenza: U.S. Government Perspective on International Issues

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Overview of Influenza Surveillance in Korea

Appendix 3: Federal Government Agencies Involved in Immunization

Science. Systems Policy Process Programs People

CIDRAP Leadership Forum Infectious Disease BRIEFING

Module 4: Emergencies: Prevention, Preparedness, Response and Recovery

Neuroscience International Funding Opportunities at NINDS & NIH

U.S. House of Representatives U.S. Senate. U.S. House of Representatives U.S. Senate

Public Health and Medical Preparedness and Response: Issues in the 110 th Congress

Local Government Pandemic Influenza Planning. Mac McClendon, Chief / Office of Public Health Preparedness Emergency Management Coordinator


April 15, Barbara A. Bowman, PhD Acting Director, DCPC

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)

Viral Hepatitis in the U.S.: Federal Partner Update

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations

GAO INFLUENZA PANDEMIC. Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning. Report to Congressional Requesters

Update of The National Vaccine Plan

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

Application of Single-Use Technologies in Medical Countermeasure Development & Manufacturing for Emerging Pathogens

Background. Why Policymakers Should be Concerned

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

Resolution. REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN October 2009

NIDA/FDA Collaborations

DRAFT PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE PLAN. Department of Health and Human Services. Core Document August 2004

Successful Collaboration and Preparedness in Global Governance

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine

Association of Public Health Laboratories

Infectious Diseases Michigan Department of Health and Human Services, Bureau of Epidemiology and Population Health Assignment Description

Modelling and Simulation in Public Health

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

Preparing for the Unexpected

The H5N1 Influenza Controversy: Implications for Science Governance. Larry Kerr, PhD Senior Advisor to the Director for Global Biological Threats

March 8, Written Testimony for FY 2018 Appropriations for the Department of Health and Human Services

Approximately 6 years ago, then-president

Pandemic Preparedness: People, Plans, Products, and Practice. Julie Louise Gerberding, MD, MPH

2013 NEHA AEC July 9 11, One Health and All-Hazards: the New Environmental Health. Want this on you?

Public Health Preparedness and Response Update

Transcription:

FY 2008 Appropriations for R&D and Public Health Programs (in millions) AGENCY PROGRAM FY 2008 Appropriations Status: http://thomas.loc.gov/home/approp/app08.html FY 2008 : http://www.whitehouse.gov/omb/budget/fy2007/ Agency s: http://www.asm.org/policy/index.asp?bid=48354 10/26/07 PB % PB % PB National Institutes of Health* $28,899 $28,621-1.0% $29,650 2.6% ** 3.6% $29,900 3.5%** 4.5% NCI $4,798 $4,782-0.3% $4,870 1.5% 1.8% $4,910 2.3% 2.7% NHLBI $2,923 $2,925 0.1% $2,966 1.5% 1.4% $2,992 2.4% 2.3% NIDCR $390 $390 0.0% $396 1.5% 1.5% $399 2.3% 2.3% NIDDK $1,706 $1,708 0.1% $1,732 1.5% 1.4% $1,748 2.5% 2.3% NINDS $1,536 $1,537 0.1% $1,559 1.5% 1.4% $1,573 2.4% 2.3% NIAID ** $4,368 $4,592 5.1% $4,632 6.0% 0.9% $4,668 6.9% 1.7% NIGMS $1,936 $1,941 0.3% $1,966 1.5% 1.3% $1,979 2.2% 2.0% NICHD $1,255 $1,265 0.8% $1,274 1.5% 0.7% $1,282 2.2% 1.3% NEI $667 $668 0.1% $677 1.5% 1.3% $682 2.2% 2.1% NIEHS $642 $637-0.8% $652 1.6% 2.4% $656 2.2% 3.0% NIA $1,047 $1,047 0.0% $1,063 1.5% 1.5% $1,073 2.5% 2.5% NIAMS $508 $508 0.0% $516 1.6% 1.6% $520 2.4% 2.4% NIDCD $394 $394 0.0% $400 1.5% 1.5% $403 2.3% 2.3% NIMH $1,404 $1,405 0.1% $1,426 1.6% 1.5% $1,436 2.3% 2.2% NIDA $1,001 $1,000-0.1% $1,016 1.5% 1.6% $1,023 2.2% 2.3% NIAAA $436 $437 0.2% $443 1.6% 1.4% $446 2.3% 2.1% NINR $137 $138 0.7% $140 2.2% 1.4% $140 2.2% 1.4% NHGRI $486 $484-0.4% $494 1.6% 2.1% $497 2.3% 2.7% NIBIB $297 $300 1.0% $303 2.0% 1.0% $304 2.4% 1.3% NCRR $1,133 $1,112-1.9% $1,171 3.4% 5.3% $1,178 4.0% 5.9% NCCAM $122 $122 0.0% $123 0.8% 0.8% $124 1.6% 1.6% NCMHD $199 $194-2.5% $203 2.0% 4.6% $204 2.5% 5.2% FIC $66 $67 1.5% $68 3.0% 1.5% $68 3.0% 1.5% NLM $329 $321-2.4% $325-1.2% 1.2% $328-0.3% 2.2% OD *** $1,047 $517-50.6% $1,114 6.4% 115.5% $1,146 9.5% 121.7% B&F $81 $136 67.9% $121 49.4% -11.0% $121 49.4% -11.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** The FY 2008 Request for NIAID, the FY 2008 and the FY 2008 Committee, include $300 million that would transfer to the Global Fund for HIV/AIDS, TB; the FY 2007 Joint Resolution includes approximately $99 million for the Global Fund. The recommendation for NIH for FY 2008 is 2.8% over FY 2007, when adjusted for the Global Fund transfer and the recommendation is a 1.9 percent increase when adjusted. *** The FY 2007 funding level directs $483 million to be used for the Common Fund and $69 million is for the National Children's Study; the FY 2008 directs $495 million to the Common Fund and $110.9 million to the National Children's Study; the FY 2008 Committee directs $531 million to the Common Fund and $110.9 million to the National Children's Study. The and specify the amount for the Common Fund, authorized int he 2006 NIH Reform Act, and do not transfer the 1.3 percent each IC for the Common fund that is in the budget request for FY 2008. American Society for Microbiology 1

AGENCY PROGRAM PB % PB % PB Centers for Disease Control & Prevention * $6,203 $5,983-3.5% $6,449 4.0% 7.8% $6,427 3.6% 7.4% Infectious Diseases $1,804 $1,794-0.6% $1,912 6.0% 6.6% $1,775-1.6% -1.1% Pandemic Influenza $70 $158 125.7% $158 125.7% 0.0% $158 125.7% 0.0% HIV/AIDS, Viral Hepatities, STDs, TB Prevention ** $1,010 $1,057 4.7% $1,041 3.1% -1.5% $1,020 1.0% -3.5% Zoonotic, Vector-Borne, and Enteric Diseases $70 $63-10.0% $70 0.0% 11.1% $70 0.0% 11.1% Hanta Virus/Special Pathogens $4 $4 0.0% Lyme Disease $5 $5 0.0% West Nile Virus $37 $20-45.9% $37 0.0% 85.0% Food Safety $29 $29 0.0% Chronic Fatigue Syndrome $5 $5 0.0% Preparedness, Detection, and Control of Infectious Diseases $156 $130-16.7% $164 5.1% 26.2% $157 0.6% 20.8% Antimicrobial Resistance $17 $17 0.0% $19 11.8% 11.8% Patient Safety $3 $3 0.0% All Other Emerging Infectious Diseases $104 $109 4.8% $137 31.7% 25.7% Global Health $334 $380 13.8% $381 14.1% 0.3% $334 0.0% -12.1% Environmental Health and Injury $288 $288 0.0% $305 5.9% 5.9% $296 2.8% 2.8% Buildings & Facilities $134 $20-85.1% $20-85.1% 0.0% $220 64.2% 1000.0% Terrorism Preparedness and Response (Bioterrorism) $1,541 $1,504-2.4% $1,589 3.1% 5.7% $1,632 5.9% 8.5% * The adopted an amendment sponsored by Senators Harkin (D-IA), Kennedy (D-MA), and Specter (R-PA), that states $5,000,000 shall be for activities to reduce infections methicillin-resistant staphylococcus aureus (MRSA) and related infections. The $5 million will be provided by the appropriated sums under the Agency for Healthcare Research and Quality to focus on identifying and containing. * The adopted an amendment sponsored by Senator Coburn (R-OK), that eliminates wasteful spending by the Centers for Disease Control and Prevention, specifying that none of the funds provided to the CDC shall be used for the Ombudsman Program or additional rotating paste lights, zero-gravity chairs, or dry-heat saunas for its fitness center. * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** The adopted an amendment, sponsored by Senator Enzi (R-WY), that would bar the use of funds in the bill to modify funding formulas for HIV/AIDS programs under Title XXVI of the Public Health Service Act, preventing a redistribution of HIV/AIDS funds included in the bill. American Society for Microbiology 2

AGENCY PROGRAM PB % HHS-Wide Pandemic Influenza */** $164 $1,192 626.8% $1,146 Activities Funded with No-Year Funding PB % PB HHS Office of the Secretary Public Health and Social Services $948 $948 0.0% $888-6.3% Emergency Fund ** Vaccines and Antivirals: Achieve Production Capacity and/or Buy Vaccine $543 $652 20.1% Purchase Antivirals $248 Advanced Deveopment of Antigen Sparing Techniques and Antiviral Drugs Enhance Strategic National Stockpile State and Local Preparedness Antiviral Subsidy to States Vaccine Registry Rapid Diagnostics (CDC) $79 HHS Office of the Secretary $79 $78-1.3% $78-1.3% 0.0% $78-1.3% 0.0% Activities Funded in the Agency s CDC $70 $158 $158 125.7% 0.0% $158 0.0% FDA $50 $51 2.0% NIH $35 $35 0.0% $35 0.0% 0.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. **The FY 2008 Request for HHS-Wide Pandemic Influenza activites includes $870 million to fund the development of vaccines, antiviral drugs, and new tests to rapidly diagnose the disease, while $322 million would fund ongoing activities withing the CDC, FDA, NIH, and the Office of the Secretary. The FY 2008 Committee for HHS-Wide Pandemic Influenza activites includes $652 million to be available until expended fund the pre-pandemic vaccine for stockpiling,vaccine development, antiviral drugs, and research and development of diagnostic tests, while $78 million would fund ongoing activities within the the Office of the Secretary, and $158 million would be trasferred to the CDC to fund ongoing pandemic influenza activities. The FY 2008 for HHS-Wide Pandemic Influenza activities includes $870 million to fund the development of vaccines, antiviral drugs, and new tests to rapidly diagnose the disease, while $271 million would fund ongoing activities withing the CDC, NIH, and the Office of the Secretary. Since FY 2006, the Federal government has provided approximately $7 billion for pandemic influenza. FY 2007 Emergency Supplemental Pandemic Influenza HHS Office of the Secretary Public Health and Social Services Emergency Fund * $663 * These funds are intended for the purchase of antivirals, vaccine capacity building, retrofitting production facilities and accelerating the development of cell-based vaccines. Tuberculosis (TB) CDC $137 $137 0.0% $147 7.3% 7.3% NIH NIAID $129 Department of State * $50 * The adopted an amendment by Donald M. Payne, D-N.J., to shift $50 million in the bill to tuberculosis treatment, by taking $25 million within the child survival and health account and $25 million the economic support fund. According to preliminary reports, funding would go to Africa, to purchase drugs, train health care workers and build and equip and operate laboratories. American Society for Microbiology 3

AGENCY PROGRAM HHS-Wide Bioterrorism and Emergency Response Activities PB % PB % PB $4,148 $4,289 3.4% Centers for Disease Control and Prevention $1,541 $1,504-2.4% $1,589 3.1% 5.7% $1,632 5.9% 8.5% Biosurveillance Initiative $78 $88 12.8% $81 3.8% -8.0% $78 0.0% -11.4% CDC Capacity $137 $137 0.0% $137 0.0% 0.0% $137 0.0% 0.0% State and Local Capacity $824 $698-15.3% $790-4.1% 13.2% $760-7.8% 8.9% Strategic National Stockpile $491 $581 18.3% $581 18.3% 0.0% $581 18.3% 0.0% Anthrax Research Study $14 $0 $10-28.6% Quarantine Stations $11 National Institutes of Health $1,731 $1,723-0.5% Biodefense Research $1,610 $1,628 1.1% Radiological/Nuclear/Chemical Countermeasures Research $97 $96-1.0% $95-2.1% -1.0% $96-1.0% 0.0% Extramural Laboratory Construction $25 $0 Food and Drug Administration $217 $242 11.5% Food Defense $156 $178 14.1% Vaccines/Drugs/Diagnostics $55 $57 3.6% Physical Security $7 $7 0.0% $652 $781 19.8% Operations $9 $13 44.4% Preparedness and Emergency Operations $15 $48 220.0% National Disaster Medical System $47 $53 12.8% $53 12.8% 0.0% $53 12.8% 0.0% HHS Office of the Secretary Hospital Preparedness Grants ** $367 $414 12.8% $451 22.9% 8.9% $439 19.6% 6.0% Training and Curriculum Development ** $21 $0 International Early Warning Surveillance $9 $9 0.0% Media/Public Information Campaign $3 $2-33.3% Other 19 30 57.9% BARDA *** $211 $162-23.2% Advanced Research and Development **** $99 $189 90.9% $140 41.4% -25.9% $189 90.9% 0.0% BioShield Management $22 $22 0.0% $22 0.0% * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. ** Reflects comparable adjustments in FY 2006 and FY 2007 the Health Resources and Services Administration (HRSA) to the Office of the Secretary for preparedness and emergency response programs. *** Biomedical Advanced Research and Development Authority (BARDA), a newly created authority to coordinate research and produce vaccines an countermeasures against potential plagues and bioweapons. **** Reflects comparable adjustments in FY 2006 and FY 2007 of $50 million the NIAID to the Office of the Secretary for advanced development of biodefense countermeasures. **** The adopted and amendment, sponsored by Senator Burr (R-NC), that increases funding for the Public Health and Social Services Emergency Fund (PHSSEF) by $30 million to be used for the development of biodefense medical countermeasures by fully funding the Biomedical Advanced Research and Development Authority (BARDA). It specifically inserts the following under the PHSSEF section that $189,000,000 shall be used to support advanced research and development of medical countermeasures, consistent with section 319L of the Public Health Service Act. This $30 million increase is funded through a $30 million decrease in the Department of Education appropriation. American Society for Microbiology 4

AGENCY PROGRAM PB % PB % PB Food and Drug Administration (Includes drug, device, and animal drug user fees; and Buildings and $1,982 $2,042 3.0% $1,710-13.7% -16.3% $2,281 15.1% 11.7% Facilities) Foods $457 $467 2.2% $467 2.2% 0.0% $522 14.2% 11.8% Human Drugs $315 $324 2.9% $324 2.9% 0.0% $356 13.0% 9.9% Biologics $145 $155 6.9% $155 6.9% 0.0% $159 9.7% 2.6% Animal Drugs and Feeds $95 $95 0.0% $95 0.0% 0.0% $98 3.2% 3.2% Medical Devices $231 $240 3.9% $240 3.9% 0.0% $243 5.2% 1.3% * The levels are based on the Appropriations Committee recommended levels. * The FY 2007 and FY 2008 levels are based on the FY 2008 Committee Report. Department of Homeland Security Science and Technology Directorate (Research, Development, Acquisitions, and Operations) $749 $657-12.3% $646-13.8% -1.7% $697-6.9% 6.1% Chemical and Biological * $229 $229 0.0% $215-6.1% -6.1% $216-5.7% -5.7% Laboratory Facilities ** $106 $88-17.0% $89-16.0% 1.1% $104-1.9% 18.2% University Programs $49 $39-20.4% $49 0.0% 25.6% $39-20.4% 0.0% BioWatch $78 $79 1.3% $77-1.3% -2.5% $79 1.3% 0.0% National Biosureillance Integration System $8 $8 0.0% $8 0.0% 0.0% $8 0.0% 0.0% * The FY 2007 level and FY 2008 reflect transfers of $84 million out of the Science and Technology Directorate Chemical and Biological program to the Office of Health Affairs for biosurveillance, the BioWatch program, and chemical response activities, which took place on March 31, 2007. The has also provided $28,170,000 for the Department s Science and Technology Directorate to fully fund the ongoing BioWatch generation 3 research to begin validation and pilot testing of three different prototypes and complete signatures to identify pathogens of concern. ** The FY 2008 and provide $11,000,000 is for the National Bio and Agrodefense Facility to be used to continue environmental studies necessary to determine which site will be selected for this nextgeneration biological and agricultural defense facility with construction is anticipated to begin in 2010. National Science Foundation * $5,981 $6,429 7.5% $6,499 8.7% 1.1% $6,553 9.6% 1.9% Biological Sciences Directorate $608 $633 4.1% Research & Related Activities $4,666 $5,132 10.0% $5,140 10.2% 0.2% $5,156 10.5% 0.5% Major Research Equipment & Facilities Construction $234 $245 4.7% $245 4.7% 0.0% $245 4.7% 0.0% Education & Human Resources $700 $750 7.1% $823 17.6% 9.7% $851 21.6% 13.5% * The adopted an amendment by Shelley Moore Capito (R-WV), to shift $10 million the NSF to the Office on Violence Against Women. American Society for Microbiology 5

AGENCY PROGRAM Department of Energy (Office Science) PB % PB % PB $3,797 $4,398 15.8% $4,514 18.9% 2.6% $4,497 18.4% 2.3% Basic Energy Sciences $1,197 $1,498 25.1% $1,498 25.1% 0.0% $1,512 26.3% 0.9% Biological and Environmental Research * / ** $462 $532 15.2% $582 26.0% 9.4% $605 31.0% 13.7% Biological Research $424 Climate Research $158 * The levels are based on the Appropriations Committee recommended levels. * The FY 2007 Joint Funding Resolution strips earmarks the BER budget, providing funding for the base BER research programs, the FY 2008 does the same. ** The FY 2008 notes that BER encompasses tow distinct efforts, Biological Research and Climate Research, and provides funding in separate subaccounts, and urges this practice in future fiscal years. Environmental Protection Agency * $7,725 $7,199-6.8% $8,086 4.7% 12.3% $7,773 0.6% 8.0% Science & Technology (not including the Superfund Transfers) $733 $755 3.0% $788 7.5% 4.4% $773 5.5% 2.4% Office of Research and Development $555 $540-2.7% $570 2.7% 5.6% Extramural Research Grants $14 STAR Grants ** $62 $56-9.7% STAR Fellowships $9 $6-33.3% $11 22.2% 83.3% * The levels are based on the Appropriations Committee recommended levels. ** The FY 2008 does not provide a specific funding level for the STAR Grants, but states that the Committee continues to stress the importance of the STAR program and has attempted to target increases in areas that will both expand research and support STAR programs, and finds reductions to STAR funding not acceptable. Targeted increases include a $20 million increase over FY 2007 in S&T Clean Air research, and a $5 million increase in S&T Clean Water research. American Society for Microbiology 6

AGENCY PROGRAM PB % PB % PB U.S. Department of Agriculture * $17,812 $17,830 0.1% $18,817 5.6% 5.5% $18,709 5.0% 4.9% CSREES $1,177 $1,044-11.3% $1,145-2.7% 9.7% $1,172-0.4% 12.3% National Research Initiative * $190 $257 35.3% $190 0.0% -26.1% $244 28.4% -5.1% Agricultural Research Service (not including Buildings and Facilities) $1,129 $1,022-9.5% $1,076-4.7% 5.3% $1,154 2.2% 12.9% Food Safety and Inspection Service $892 $930 4.3% $930 4.3% 0.0% $931 4.4% 0.1% APHIS (not including Buildings and $846 $946 11.8% $875 3.4% -7.5% $912 7.8% -3.6% Facilities) * The levels are based on the Appropriations Committee recommended levels. * Water Quality and Food Safety Integrated Activities, totaling $42 million, are shifted to NRI in the FY 2008 request and the Committee. The Committee does not include the transfer of programs, but does direct the Secretary to provide the requested increase for bioenergy and bio-based fuels research within the funds provided. National Aeronautics and Space Administration National Oceanic and Atmospheric Administration $16,264 $17,309 6.4% $17,599 8.2% 1.7% $17,460 7.4% 0.9% Science $5,251 $5,516 5.0% $5,696 8.5% 3.3% $5,655 7.7% 2.5% * The adopted an amendment, sponsored by Senator Mikulski (D-MD), appropriating $10 million to a cross-agency effort to distribute, in equal increments, to each of NASA s 10 centers for the development of educational activities in science, technology, engineering, and mathematics related to the civilian space program of the United States Operations, Research, and Facilities $2,813 $2,855 1.5% $2,860 1.7% 0.2% $3,037 8.0% 6.4% U.S. Geologic Survey $983 $975-0.8% $1,033 5.1% 5.9% $1,010 2.7% 3.6% Biological Research Division $178 $181 1.7% $187 5.1% 3.3% $182 2.2% 0.6% Water Resource Division $215 $212-1.4% $223 3.7% 5.2% $224 4.2% 5.7% * The levels are based on the Appropriations Committee recommended levels. American Society for Microbiology 7